Substantia nigra alterations in mice modeling Parkinson's disease

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Parkinson's disease (PD) is an age-related neurodegenerative disorder affecting the central nervous system.
• Key pathological hallmarks include nigrostriatal system dysfunction and alpha-synuclein aggregation.
• Genetic mouse models are crucial for understanding PD mechanisms.

Purpose of the Study:

• To investigate motor coordination, body balance, dopaminergic neuronal density, and alpha-synuclein accumulation in a specific PD mouse model (B6.Cg-Tg).
• To evaluate the B6.Cg-Tg mouse strain as a model for early-stage Parkinson's disease.

Main Methods:

• Utilized the B6.Cg-Tg mouse strain, engineered with the human SNCA gene harboring the A53T mutation.
• Assessed motor coordination and body balance using the rota-rod test.
• Employed immunohistochemistry to evaluate dopaminergic neuron density and alpha-synuclein accumulation in the substantia nigra.

Main Results:

• No significant differences in motor coordination or body balance were observed between B6.Cg-Tg mice and wild-type controls.
• B6.Cg-Tg mice exhibited significant alpha-synuclein accumulation in the substantia nigra.
• A notable decrease in dopaminergic neuron density was found in the substantia nigra of B6.Cg-Tg mice.

Conclusions:

• Six-month-old B6.Cg-Tg mice display key pathological features of early Parkinson's disease, including alpha-synucleinopathy and dopaminergic neurodegeneration.
• Despite the absence of motor deficits at this age, the B6.Cg-Tg strain is a relevant model for studying the initial stages of PD.
• This model offers potential for investigating therapeutic strategies targeting early PD pathogenesis.